Wuhan Hvsen Biotechnology Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Net Income	253.49	-20.16	16.78	52.71	132.87
Depreciation & Amortization	120.37	113.13	120.39	62.57	28.54
Other Amortization	0.95	0.91	0.63	0.12	-
Loss (Gain) From Sale of Assets	-	-	-	-0.01	-
Asset Writedown & Restructuring Costs	1.64	0.21	0.67	0.51	0.06
Loss (Gain) From Sale of Investments	-8.89	15.45	-25.37	-7.01	-4.4
Provision & Write-off of Bad Debts	-	-1.68	24.94	10.77	-7.07
Other Operating Activities	22.69	45.54	31.08	9.05	6.31
Change in Accounts Receivable	-43.45	-210.12	-109.82	14.44	21.69
Change in Inventory	-22.94	-20.83	-28.06	30.42	-105.92
Change in Accounts Payable	-83.73	136.38	71.98	-71.04	67.53
Change in Other Net Operating Assets	2.61	4.26	-	-0.94	18.31
Operating Cash Flow	238.45	43.53	92.92	96.68	155.72
Operating Cash Flow Growth	447.76%	-53.15%	-3.89%	-37.91%	222.07%
Capital Expenditures	-96.92	-194.43	-184.31	-428.87	-600.12
Sale of Property, Plant & Equipment	0.4	0.42	-	0.07	0.1
Investment in Securities	34.58	84	69.85	-330	410
Other Investing Activities	7.1	8.19	14.16	9.25	4.87
Investing Cash Flow	-54.84	-101.81	-100.3	-749.54	-185.15
Short-Term Debt Issued	-	56.59	53.92	221.37	-
Long-Term Debt Issued	220	480	210.85	-	135.21
Total Debt Issued	220	536.59	264.77	221.37	135.21
Long-Term Debt Repaid	-368.08	-479.56	-244.3	-139.8	-73.52
Total Debt Repaid	-368.08	-479.56	-244.3	-139.8	-73.52
Net Debt Issued (Repaid)	-148.08	57.04	20.47	81.57	61.69
Issuance of Common Stock	-	16.35	-	-	700.96
Repurchase of Common Stock	-	-3.26	-3.31	-53.68	-
Common Dividends Paid	-49.92	-59.16	-58.63	-62.48	-47.94
Other Financing Activities	37.76	3	-	-0.01	-4.63
Financing Cash Flow	-160.24	13.98	-41.48	-34.6	710.09
Foreign Exchange Rate Adjustments	-1.84	-0.61	-0.23	-0.07	-0.03
Net Cash Flow	21.53	-44.92	-49.09	-687.53	680.63
Free Cash Flow	141.53	-150.89	-91.39	-332.18	-444.4
Free Cash Flow Margin	8.42%	-12.57%	-8.96%	-32.48%	-44.61%
Free Cash Flow Per Share	0.72	-0.91	-0.55	-2.01	-2.68
Cash Income Tax Paid	73.77	40.27	41.25	0.09	1.6
Levered Free Cash Flow	108.62	-159.5	-223.53	-217.62	-467.49
Unlevered Free Cash Flow	108.62	-132.83	-205.9	-206.14	-465.69
Change in Working Capital	-151.8	-109.88	-76.2	-32.04	-0.58

Source: S&P Global Market Intelligence. Standard template. Financial Sources.